Ascentage Pharma Group International (HKG:6855)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
45.96
+3.20 (7.48%)
At close: Mar 27, 2026

HKG:6855 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
15,73819,23014,0717,7726,6367,264
Market Cap Growth
19.77%36.66%81.06%17.11%-8.65%-14.53%
Enterprise Value
15,20319,30114,7277,8856,4756,225
Last Close Price
42.7652.2545.4527.3025.7028.20
Forward PE
34.74154.05----
PS Ratio
24.6330.1013.4831.7827.99212.05
PB Ratio
10.6012.9548.2399.8714.364.79
P/TBV Ratio
11.4614.0180.87-19.595.15
EV/Sales Ratio
23.8030.2114.1132.2427.31181.70
Debt / Equity Ratio
1.481.486.0925.424.390.88
Net Debt / Equity Ratio
-0.37-0.371.479.840.71-0.54
Net Debt / EBITDA Ratio
0.430.43-1.34-0.85-0.340.73
Net Debt / FCF Ratio
---2.96-0.90-0.340.64
Asset Turnover
0.170.170.380.080.070.01
Inventory Turnover
2.782.782.562.383.29-
Quick Ratio
1.661.661.171.351.785.05
Current Ratio
1.791.791.261.441.865.22
Return on Equity (ROE)
-154.56%-154.56%-235.32%-386.28%-107.45%-75.18%
Return on Assets (ROA)
-23.02%-23.02%-9.25%-20.92%-19.14%-24.97%
Return on Capital Employed (ROCE)
-52.20%-52.20%-26.10%-57.00%-45.30%-36.20%
Earnings Yield
-8.79%-7.19%-3.07%-13.12%-15.04%-13.22%
FCF Yield
---1.03%-10.95%-14.60%-17.57%
Buyback Yield / Dilution
-17.89%-17.89%-7.00%-7.07%-3.56%-17.93%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.